Jason Rickard - Dec 16, 2021 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role: SVP, Chief Operating Officer
Signature: /s/ Brian Tessler, Attorney-in-Fact
Stock symbol: IRWD
Transactions as of: Dec 16, 2021
Transactions value $: -$304,560
Form type: 4
Date filed: 12/20/2021, 03:08 PM
Previous filing: Nov 24, 2021
Next filing: Jan 21, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IRWD	Class A Common Stock	Sale	-$305K	-27K	-7.78%	$11.28	320K	Dec 16, 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.28 to $11.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2	The reporting person acquired 2,236 shares of Class A common stock under the issuer's employee stock purchase plan on June 30, 2021.

Content

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.28 to $11.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The reporting person acquired 2,236 shares of Class A common stock under the issuer's employee stock purchase plan on June 30, 2021.